Related Experiment Video
Updated: Jun 1, 2026
09:44
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Dysplasia in ulcerative colitis: still a challenge.
Mauro Frego1, Marco Scarpa, Alessio Bridda
1Dept. of Surgical and Gastroenterological Sciences PG Cevese, University of Padua, Padua, Italy. mauro.frego@unipd.it
Annali Italiani Di Chirurgia
|June 11, 2011
Summary
Inflammatory bowel disease (IBD) increases colorectal cancer (CRC) risk. Regular screening colonoscopies and biopsies are crucial for early detection and management of dysplasia in ulcerative colitis (UC) patients.
Area of Science:
- Gastroenterology and Oncology
- Clinical Medicine
Background:
- Inflammatory bowel disease (IBD), particularly ulcerative colitis (UC), is a significant risk factor for colorectal cancer (CRC).
- The duration of IBD correlates with an increased risk of CRC development.
Purpose of the Study:
- To outline screening and management strategies for colorectal cancer in patients with ulcerative colitis.
- To discuss the implications of dysplasia detection on treatment decisions.
Main Methods:
- Review of current literature and meta-analyses on IBD, UC, and CRC.
- Analysis of risk factors, screening intervals, and treatment options for dysplasia.
Main Results:
- Screening colonoscopy is recommended 8-10 years after IBD onset.
- Low-grade dysplasia may warrant closer surveillance (3-6 month intervals) or colectomy, while high-grade dysplasia often necessitates surgery.
- Restorative proctocolectomy carries a risk of dysplasia in the anal transition zone and rectal cuff.
Conclusions:
- Early and consistent surveillance is vital for managing CRC risk in UC patients.
- Treatment decisions for dysplasia should be individualized based on grade and patient factors.
- Post-surgical monitoring is essential after restorative proctocolectomy.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...